jCyte is currently recruiting patients with retinitis pigmentosa
Steven Wang is a fellow COA/OCOS Board Member. He serves as the Director of Central Testing Facility for jCyte, Inc. jCyte is currently recruiting patients with retinitis pigmentosa for their Phase 2 clinical trial, with regional clinical trial sites at UCI (850 Health Sciences Road, Irvine, CA 92697) and RVA (9001 Wilshire Blvd, Ste 301, Beverly Hills, CA 90211). Please help us spread the word to our fellow colleagues.